Labiana Health, S.A. (BME:LAB)
Spain · Delayed Price · Currency is EUR 3.900
+0.040 (1.04%)
At close: Aug 8, 2025, 5:30 PM CET
Labiana Health Revenue
In the year 2024, Labiana Health had annual revenue of 67.37M EUR with 12.86% growth. Labiana Health had revenue of 31.75M in the half year ending December 31, 2024, with 2.85% growth.
Revenue
67.37M
Revenue Growth
+12.86%
P/S Ratio
0.41
Revenue / Employee
182.59K
Employees
369
Market Cap
27.46M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 67.37M | 7.68M | 12.86% |
| Dec 31, 2023 | 59.70M | -1.06M | -1.74% |
| Dec 31, 2022 | 60.76M | 1.31M | 2.21% |
| Dec 31, 2021 | 59.44M | -658.32K | -1.10% |
| Dec 31, 2020 | 60.10M | 9.40M | 18.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.45B |
| Laboratorios Farmaceuticos Rovi | 749.00M |
| Almirall | 1.05B |
| Pharma Mar | 189.27M |
| Faes Farma | 543.77M |
| Clínica Baviera | 288.92M |
| Laboratorio Reig Jofre | 336.02M |
| Atrys Health | 218.10M |